高选择性快速分离嗜血杆菌属XV琼脂培养基生物医学新产品研究与开发精选.pdfVIP

Hans Journal of Biomedicine 生物医学, 2015, 5, 1-8 Published Online January 2015 in Hans. /journal/hjbm /10.12677/hjbm.2015.51001 Research and Development of Biomedical New Products of Selective Fast Separation Haemophilus Genus XV AGAR Medium Ruili Yao Tianjin Chuanhe Medical Technology Co., Ltd., Tianjin Email: ycbyrl@163.com th rd th Received: Apr. 7 , 2015; accepted: Apr. 23 , 2015; published: Apr. 29 , 2015 Copyright © 2015 by author and Hans Publishers Inc. This work is licensed under the Creative Commons Attribution International License (CC BY). /licenses/by/4.0/ Abstract Haemophilus influenzae (Hi) is a key to respiratory tract infection pathogens, clinical disease for meningitis, pneumonia, cellulitis, sepsis, osteomyelitis and cp, and is the most common disease in pediatric hospital. The strain infection directly harms the people healthy body. How to quickly detect infection strain cultivation, convenient for the doctor’s right medication for a long time, fo- cuses on major issues. Because the wide detection range, the low sensitivity and the poor accuracy of the conventional in vitro diagnostic reagents result in the low separation rate and the poor de- tection rate, providing biomedical new products of selective fast separation Haemophilus genus XV agar medium to clinic has be imperative. By using the factorial effect, the product adds X and V factors to prepare the sterile culture medium. It does not need to add blood so as to avoid the problems such as blood collection, bacterial contamination and high cost, and to achieve the high- est purity in China. Rapid isolation of Haemophilus XV aga